These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7523655)

  • 1. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
    Hartman JC; Kurc GM; Hullinger TG; Wall TM; Sheehy RM; Shebuski RJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1071-6. PubMed ID: 7523655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits.
    Hoshida S; Yamashita N; Igarashi J; Nishida M; Hori M; Kamada T; Kuzuya T; Tada M
    J Pharmacol Exp Ther; 1995 Jul; 274(1):413-8. PubMed ID: 7542338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.
    Hartman JC; Hullinger TG; Wall TM; Shebuski RJ
    Eur J Pharmacol; 1993 Apr; 234(2-3):229-36. PubMed ID: 8482328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
    Hartman JC; Wall TM; Hullinger TG; Shebuski RJ
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):996-1003. PubMed ID: 7687728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
    Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
    Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
    Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
    Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
    Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury.
    Schulz R; Wambolt R
    Cardiovasc Res; 1995 Sep; 30(3):432-9. PubMed ID: 7585835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
    Davani S; Vergely C; Royer B; Bouhaddi M; Reyssie H; Rochette L; Kantelip JP
    Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL868-73. PubMed ID: 17543224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin does not prevent the attenuation of myocardial stunning by the ACE inhibitor ramiprilat.
    Rose J; Ehring T; Sakka SG; Skyschally A; Heusch G
    J Mol Cell Cardiol; 1996 Mar; 28(3):603-13. PubMed ID: 9011643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
    Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
    Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage.
    Zhang F; Xu S; Iadecola C
    J Cereb Blood Flow Metab; 1995 Jul; 15(4):595-601. PubMed ID: 7540621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts--comparison of the effects of pioglitazone and metformin.
    Kawabata H; Ishikawa K
    Diabetes Metab Res Rev; 2003; 19(4):299-305. PubMed ID: 12879407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide mitigates leukocyte adhesion and vascular leak after myocardial ischemia.
    Kupatt C; Zahler S; Seligmann C; Massoudy P; Becker BF; Gerlach E
    J Mol Cell Cardiol; 1996 Mar; 28(3):643-54. PubMed ID: 9011647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart.
    Patel VC; Yellon DM; Singh KJ; Neild GH; Woolfson RG
    Biochem Biophys Res Commun; 1993 Jul; 194(1):234-8. PubMed ID: 8333838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.
    Schriefer JA; Broudy EP; Hassen AH
    J Pharmacol Exp Ther; 2001 Sep; 298(3):970-5. PubMed ID: 11504792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
    Das B; Sarkar C
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.